|
Volumn 300, Issue 5616, 2003, Pages 33-
|
Drug safety: Conflict-of-interest allegations derail inquiry into antidepressant's 'Dark side'
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
FLUOXETINE;
PAROXETINE;
SEROTONIN UPTAKE INHIBITOR;
BEHAVIOR;
CONFLICT;
CONTROL SYSTEM;
DEPRESSION;
HUMAN;
MENTAL HEALTH SERVICE;
NOTE;
PRIORITY JOURNAL;
VIOLENCE;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
CONFLICT OF INTEREST;
DEPRESSIVE DISORDER;
DRUG INDUSTRY;
FEMALE;
GREAT BRITAIN;
HUMANS;
INVESTMENTS;
MALE;
PAROXETINE;
PRODUCT SURVEILLANCE, POSTMARKETING;
SEROTONIN UPTAKE INHIBITORS;
SUICIDE;
VIOLENCE;
|
EID: 0037418853
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (2)
|
References (0)
|